VarCov Co’s Iovance Biotherapeutics IOVA Stock Holding History

VarCov Co’s Portfolio IOVA Stock Details IOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-74,536	Closed	-$262K	–	461
2026 Q1	$262K	Sell	74,536 -18,270	-20%	-$58.4K	0.1%	310
2025 Q4	$253K	Buy	+92,806	New	+$215K	0.1%	358

Other funds holding IOVA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

MFM

MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

VarCov Co's IOVA Position: Q2 2026 in Review

VarCov Co sold out of Iovance Biotherapeutics (IOVA) in Q2 2026, closing a stake of 74,536 shares — an estimated $262K sold.

VarCov Co first reported a position in IOVA in Q4 2025 and held it in 2 quarters. The position peaked at $262K in Q1 2026. 288 funds tracked by Wall St. Rank hold IOVA as of Q2 2026.

VarCov Co reported no remaining Iovance Biotherapeutics position as of Q2 2026 after selling out during the quarter.
VarCov Co sold 74,536 Iovance Biotherapeutics shares in Q2 2026, an estimated $262K.
VarCov Co first reported a position in Iovance Biotherapeutics in Q4 2025 and held it in 2 quarters.
VarCov Co's Iovance Biotherapeutics position peaked at $262K in Q1 2026.
288 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2026.

Based on VarCov Co's 13F filing for Q2 2026, filed 14 Aug 2026.